Physician profile

Michael V Orlov

Cardiovascular Disease · Brighton, MA

NPI 1407844020

$23,878.69

in general payments reported to CMS, 2019-2025

26 companies · $1,840 in 2025

The $1,840 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$6,300.00
Food and Beverage$2,627.81
Travel and Lodging$978.37

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $13,943.69 2019-2025 Ensite, Assurity, Ensite Precision
Medtronic, INC. $7,106.20 2022-2025 Advisa Dr Mri Surescan, Selectsecure, Cobalt Dr Mri Surescan
Biotronik INC. $1,055.13 2019-2025
Boston Scientific Corporation $444.34 2019-2025 Ekosonic, Watchman Flx, Watchman Access System
Medtronic Vascular, INC. $149.14 2019
Impulse Dynamics (USA) INC. $139.95 2022
Philips North America LLC $131.81 2019
E.R. Squibb & Sons, L.L.C. $120.47 2020-2025 Camzyos
Janssen Pharmaceuticals, INC $118.37 2019
Edwards Lifesciences Corporation $93.99 2024-2025
Atricure, INC. $79.27 2023
Novartis Pharmaceuticals Corporation $61.06 2024-2025
Cardiva Medical, INC. $57.81 2025 Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f
Elutia, INC. $50.09 2021
Boehringer Ingelheim Pharmaceuticals, INC. $49.35 2019-2025 Jardiance
Show all 26 companies
CompanyGeneral paymentsYearsTop products
Scpharmaceuticals INC. $44.93 2024-2025
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $34.50 2019-2025 Lifevest
Heartflow, INC. $25.95 2025
Bayer Healthcare Pharmaceuticals INC. $25.79 2025
Amgen INC. $25.15 2025 Repatha
Astrazeneca Pharmaceuticals Lp $22.30 2019
Pfizer INC. $22.11 2025
Esperion Therapeutics, INC. $19.83 2024 Nexletol
Alnylam Pharmaceuticals INC. $19.42 2024 Onpattro
Merck Sharp & Dohme LLC $19.20 2024 Verquvo
Amarin Pharma, INC. $18.84 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael V Orlov

$23,878.69

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $1,840 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/18764/michael-v-orlov

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.